Ocr Labs Global

Ocr Labs Global Limited

Turned to net liabilitiesCash down 66%ActiveLatest figures: 2023Abridged accountsCompany only6 years on the register

Private limited company registered in London, classed under “Business and domestic software development”.

Headline figures

FY to Dec 2023 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

3 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

Pro

Every figure for all 3 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

From the filed balance sheets · £

Balance sheet	2021	2022	2023
Fixed assets
Current assets
of which debtors
of which cash
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

7 balance-sheet lines and 3 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

›What does Ocr Labs Global do?

Private limited company registered in London, classed under “Business and domestic software development”.

›How much turnover does Ocr Labs Global make?

Answered in the full report

›Is Ocr Labs Global profitable?

Ocr Labs Global's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Ocr Labs Global?

Answered in the full report

›Where is Ocr Labs Global based?

Its registered office is 1-3 Strand, London, WC2N 5JR, in London.

›When was Ocr Labs Global founded?

Ocr Labs Global Limited was incorporated on 9 September 2020.

›Is Ocr Labs Global still trading?

The register lists Ocr Labs Global Limited as active.